Target intelligence / Profile preview

Tripartite motif family-like protein 2 (TRIML2)

Target
TRIML2
Molecular classification
Enzyme (E3 ubiquitin-protein ligase; probable), TRIM (tripartite motif) family protein, SPRY domain-containing protein, Other
01

Overview

Tripartite motif family-like protein 2 (TRIML2) is a protein-coding gene in the TRIM family, characterized by the presence of a RING domain, B-box, coiled-coil, and a C-terminal PRY/SPRY (also called B30.2) domain. The PRY/SPRY domain is involved in substrate/protein recognition and protein-protein interactions, and is known in other TRIM proteins to participate in innate immunity and antiviral functions. TRIML2 is a probable E3 ubiquitin-protein ligase, and may be regulated by the tumor suppressor p53 and also enhance p53 SUMOylation, suggesting a possible regulatory influence on p53-mediated cell functions. Multiple transcript variants exist due to alternative splicing. There is limited direct evidence for TRIML2 as a therapeutic target or for interacting drugs; its primary annotation is as a probable ligase, and functional paralogs include TRIML1. Disease association is minimal, with links mainly to a rare genetic syndrome rather than prominent therapeutic areas like cancer or inflammation.

Other names
SPRYD6FLJ25801SPRY domain-containing protein 6Tripartite motif family-like protein 2RING-type E3 ubiquitin transferase TRIML2probable E3 ubiquitin-protein ligase TRIML2putative E3 ubiquitin-protein ligase TRIML2
02

Biological functions

Ubiquitin-protein ligase activity (putative)May regulate p53 protein function through sumoylation enhancementPossible involvement in innate immune functions or protein-protein interactions typical of TRIM/SPRY proteins
03

Disease associations

Other (Associated with Trichorhinophalangeal syndrome, type II)

Beyond the preview

Go deeper on Tripartite motif family-like protein 2 (TRIML2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif family-like protein 2 (TRIML2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call